Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment

From February to April 2011, 46 patients (27 male and 19 female) suffering from different cancer pain were treated with an association of oxycodone/naloxone. The pain intensity of each patient was assessed by the visual analogue scale (VAS). The measurements were taken at T0 - T15 - T30 - T45 -T60 a...

Full description

Bibliographic Details
Main Author: Paolo Desio
Format: Article
Language:English
Published: Publiediting 2011-09-01
Series:Pathos
Subjects:
Online Access:https://www.pathos-journal.com/page_60.html
id doaj-87862c57e3d64d39b31f8a7311ec8da7
record_format Article
spelling doaj-87862c57e3d64d39b31f8a7311ec8da72020-11-25T02:44:50ZengPublieditingPathos1593-23542385-07442011-09-01182-3Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatmentPaolo Desio0Responsabile Ambulatorio di Terapia del Dolore Azienda Ospedaliera di Busto Arsizio, Presidio Ospedaliero di SaronnoFrom February to April 2011, 46 patients (27 male and 19 female) suffering from different cancer pain were treated with an association of oxycodone/naloxone. The pain intensity of each patient was assessed by the visual analogue scale (VAS). The measurements were taken at T0 - T15 - T30 - T45 -T60 and T75. The therapy’s efficacy, the side effects and the sleep’s quality were evaluated. The results observed were: a better control of pain which allows patients to achieve effective self-care with a sooner return to everyday life and a tendency to zero of the side effects (especially the constipation).https://www.pathos-journal.com/page_60.htmloxycodonenaloxonecancer painconstipation
collection DOAJ
language English
format Article
sources DOAJ
author Paolo Desio
spellingShingle Paolo Desio
Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
Pathos
oxycodone
naloxone
cancer pain
constipation
author_facet Paolo Desio
author_sort Paolo Desio
title Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
title_short Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
title_full Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
title_fullStr Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
title_full_unstemmed Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
title_sort associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - combination of oxycodone/naloxone for severe oncologic pain treatment
publisher Publiediting
series Pathos
issn 1593-2354
2385-0744
publishDate 2011-09-01
description From February to April 2011, 46 patients (27 male and 19 female) suffering from different cancer pain were treated with an association of oxycodone/naloxone. The pain intensity of each patient was assessed by the visual analogue scale (VAS). The measurements were taken at T0 - T15 - T30 - T45 -T60 and T75. The therapy’s efficacy, the side effects and the sleep’s quality were evaluated. The results observed were: a better control of pain which allows patients to achieve effective self-care with a sooner return to everyday life and a tendency to zero of the side effects (especially the constipation).
topic oxycodone
naloxone
cancer pain
constipation
url https://www.pathos-journal.com/page_60.html
work_keys_str_mv AT paolodesio associazioneossicodonenaloxoneperiltrattamentodeldoloreoncologicoseverocombinationofoxycodonenaloxoneforsevereoncologicpaintreatment
_version_ 1724765644862259200